Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.75 USD | -21.08% | -14.36% | -15.81% |
12:37am | Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge | RE |
01/07 | Market Update-Europe ends the day in the green, relieved after the 1st round of elections in France | RE |
Sales 2024 * | 46.35B 49.76B 4,152B | Sales 2025 * | 49.8B 53.46B 4,460B | Capitalization | 115B 123B 10,285B |
---|---|---|---|---|---|
Net income 2024 * | 7.08B 7.6B 634B | Net income 2025 * | 8.69B 9.33B 778B | EV / Sales 2024 * | 2.63 x |
Net Debt 2024 * | 6.99B 7.51B 626B | Net Debt 2025 * | 2.37B 2.54B 212B | EV / Sales 2025 * | 2.35 x |
P/E ratio 2024 * |
16.5
x | P/E ratio 2025 * |
13.3
x | Employees | 86,088 |
Yield 2024 * |
4.21% | Yield 2025 * |
4.43% | Free-Float | 87.13% |
Latest transcript on Sanofi
1 day | -21.08% | ||
1 week | -14.36% | ||
Current month | -14.14% | ||
1 month | -14.36% | ||
3 months | -14.11% | ||
6 months | -15.81% | ||
Current year | -15.81% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01/19/01 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01/22/01 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01/14/01 |
Lise Kingo
BRD | Director/Board Member | 62 | 28/20/28 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22/20/22 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 49.45 | +1.69% | 306 |
28/24/28 | 48.63 | +1.28% | 181 |
27/24/27 | 48.01 | -1.51% | 202 |
26/24/26 | 48.75 | -1.10% | 125,071 |
25/24/25 | 49.29 | +1.11% | 267 |
Delayed Quote London S.E., October 27, 2023 at 08:10 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- SAN Stock
- 0A2V Stock